165 related articles for article (PubMed ID: 12417527)
1. A cellular model for Friedreich Ataxia reveals small-molecule glutathione peroxidase mimetics as novel treatment strategy.
Jauslin ML; Wirth T; Meier T; Schoumacher F
Hum Mol Genet; 2002 Nov; 11(24):3055-63. PubMed ID: 12417527
[TBL] [Abstract][Full Text] [Related]
2. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts.
García-Giménez JL; Gimeno A; Gonzalez-Cabo P; Dasí F; Bolinches-Amorós A; Mollá B; Palau F; Pallardó FV
PLoS One; 2011; 6(6):e20666. PubMed ID: 21687738
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.
Jauslin ML; Meier T; Smith RA; Murphy MP
FASEB J; 2003 Oct; 17(13):1972-4. PubMed ID: 12923074
[TBL] [Abstract][Full Text] [Related]
5. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia.
Seznec H; Simon D; Monassier L; Criqui-Filipe P; Gansmuller A; Rustin P; Koenig M; Puccio H
Hum Mol Genet; 2004 May; 13(10):1017-24. PubMed ID: 15028670
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia.
Jauslin ML; Vertuani S; Durini E; Buzzoni L; Ciliberti N; Verdecchia S; Palozza P; Meier T; Manfredini S
Mol Cell Biochem; 2007 Aug; 302(1-2):79-85. PubMed ID: 17476463
[TBL] [Abstract][Full Text] [Related]
7. Friedreich's ataxia: from disease mechanisms to therapeutic interventions.
Lodi R; Tonon C; Calabrese V; Schapira AH
Antioxid Redox Signal; 2006; 8(3-4):438-43. PubMed ID: 16677089
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts.
Kemp K; Mallam E; Hares K; Witherick J; Scolding N; Wilkins A
PLoS One; 2011; 6(10):e26098. PubMed ID: 22016819
[TBL] [Abstract][Full Text] [Related]
10. Antioxidants and Friedreich's ataxia.
Fryer MJ
Lancet; 1999 Oct; 354(9186):1300-1. PubMed ID: 10520661
[No Abstract] [Full Text] [Related]
11. Partial correction of sensitivity to oxidant stress in Friedreich ataxia patient fibroblasts by frataxin-encoding adeno-associated virus and lentivirus vectors.
Fleming J; Spinoulas A; Zheng M; Cunningham SC; Ginn SL; McQuilty RC; Rowe PB; Alexander IE
Hum Gene Ther; 2005 Aug; 16(8):947-56. PubMed ID: 16076253
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts.
Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M
Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705
[TBL] [Abstract][Full Text] [Related]
13. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
Cooper JM; Schapira AH
Mitochondrion; 2007 Jun; 7 Suppl():S127-35. PubMed ID: 17485244
[TBL] [Abstract][Full Text] [Related]
14. Deferiprone and idebenone rescue frataxin depletion phenotypes in a Drosophila model of Friedreich's ataxia.
Soriano S; Llorens JV; Blanco-Sobero L; Gutiérrez L; Calap-Quintana P; Morales MP; Moltó MD; Martínez-Sebastián MJ
Gene; 2013 Jun; 521(2):274-81. PubMed ID: 23542074
[TBL] [Abstract][Full Text] [Related]
15. Small molecules affecting transcription in Friedreich ataxia.
Gottesfeld JM
Pharmacol Ther; 2007 Nov; 116(2):236-48. PubMed ID: 17826840
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid concentrations of idebenone in Friedreich ataxia patients.
Artuch R; Aracil A; Mas A; Monrós E; Vilaseca MA; Pineda M
Neuropediatrics; 2004 Apr; 35(2):95-8. PubMed ID: 15127307
[TBL] [Abstract][Full Text] [Related]
17. Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy.
Crombie DE; Pera MF; Delatycki MB; Pébay A
Int J Cardiol; 2016 Jun; 212():37-43. PubMed ID: 27019046
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers.
Napierala JS; Li Y; Lu Y; Lin K; Hauser LA; Lynch DR; Napierala M
Dis Model Mech; 2017 Nov; 10(11):1353-1369. PubMed ID: 29125828
[TBL] [Abstract][Full Text] [Related]
19. Novel aberrant genetic and epigenetic events in Friedreich's ataxia.
Quesada MP; Jones J; Rodríguez-Lozano FJ; Moraleda JM; Martinez S
Exp Cell Res; 2015 Jul; 335(1):51-61. PubMed ID: 25929520
[TBL] [Abstract][Full Text] [Related]
20. Friedreich ataxia: an update on animal models, frataxin function and therapies.
González-Cabo P; Llorens JV; Palau F; Moltó MD
Adv Exp Med Biol; 2009; 652():247-61. PubMed ID: 20225031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
